Xeltis presents "promising" first-in-human data on restorative ...
Xeltis announced promising preliminary results from the AXESS study on its Axess haemodialysis graft, showing 100% patency and no complications in 20 patients. The device, designed to transform into a living vessel, has facilitated over 1,200 dialysis sessions. Results will be presented at the Porto Vascular Conference.
Reference News
Xeltis presents "promising" first-in-human data on restorative ...
Xeltis announced promising preliminary results from the AXESS study on its Axess haemodialysis graft, showing 100% patency and no complications in 20 patients. The device, designed to transform into a living vessel, has facilitated over 1,200 dialysis sessions. Results will be presented at the Porto Vascular Conference.